{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T23:07:32Z","timestamp":1756076852996,"version":"3.40.5"},"reference-count":15,"publisher":"Royal College of Psychiatrists","issue":"3","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"unspecified","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["BJPsych open"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>Summary<\/jats:title>\n\t  <jats:p>Brain Health Services are second-generation memory clinics that aim to reduce the risk of progression to dementia in at-risk individuals. We describe the rationale for such a service, and comment on its novel implementation by Venkataraman and colleagues that integrates digital technologies and biomarker testing. We describe the advantages and possible limitations of such an approach, then investigate areas for further work \u2013 namely, the need to account for multiple pathologies in biomarker testing and to formulate standards for genetic counselling.<\/jats:p>","DOI":"10.1192\/bjo.2025.62","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T07:15:09Z","timestamp":1746774909000},"update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":1,"title":["Future directions for brain health clinics"],"prefix":"10.1192","volume":"11","author":[{"given":"Jerry H. K.","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6813-8493","authenticated-orcid":false,"given":"Ivan","family":"Koychev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"170","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"key":"S2056472425000626_ref10","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2024.829"},{"key":"S2056472425000626_ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30367-6"},{"key":"S2056472425000626_ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2023.5319"},{"key":"S2056472425000626_ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2023.0997"},{"key":"S2056472425000626_ref9","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15391"},{"key":"S2056472425000626_ref13","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awy146"},{"key":"S2056472425000626_ref14","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12814"},{"key":"S2056472425000626_ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-019-0485-7"},{"key":"S2056472425000626_ref11","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13859"},{"key":"S2056472425000626_ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-024-11571-2"},{"key":"S2056472425000626_ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2022.100576"},{"key":"S2056472425000626_ref5","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2022-329530"},{"key":"S2056472425000626_ref1","doi-asserted-by":"publisher","DOI":"10.1192\/pb.28.10.375"},{"key":"S2056472425000626_ref2","first-page":"190","article-title":"NICE approves drugs for Alzheimer\u2019s disease","volume":"322","author":"Kmietowicz","year":"2001","journal-title":"BMJ"},{"key":"S2056472425000626_ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(17)30031-2"}],"container-title":["BJPsych Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S2056472425000626","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T07:15:10Z","timestamp":1746774910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S2056472425000626\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":15,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["S2056472425000626"],"URL":"https:\/\/doi.org\/10.1192\/bjo.2025.62","relation":{},"ISSN":["2056-4724"],"issn-type":[{"value":"2056-4724","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"\u00a9 The Author(s), 2025. Published by Cambridge University Press on behalf of Royal College of Psychiatrists","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https:\/\/creativecommons.org\/licenses\/by\/4.0\/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"e98"}}